MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma
MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma
复制标题
DOI:
10.1245/s10434-010-1188-8
复制
发表时间:
2010-12-01
影响因子:
3.7
通讯作者:
Tanaka, Masao
中科院分区:
文献类型:
--
作者:
Ikenaga, Naoki;Ohuchida, Kenoki;Tanaka, Masao
Detection of aberrant microRNA (miR) expression may contribute to diagnosis and prognosis of various cancers. The aim of this study is to evaluate the correlation between miR-203 expression and prognosis of patients with pancreatic adenocarcinoma after curative resection.A total of 113 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma, 20 samples of chronic pancreatitis, and 8 samples of normal pancreas were obtained. We investigated the association of miR-203 expression measured by quantitative reverse-transcription polymerase chain reaction assays with clinicopathological parameters and survival times.miR-203 was overexpressed in pancreatic adenocarcinoma samples compared with chronic pancreatitis (P < 0.001) and normal pancreas (P = 0.001) samples. An association between miR-203 expression and clinicopathological factors of pancreatic adenocarcinoma was not observed. On univariate analysis, the high-miR-203 group and the subgroup (20%) of cases with the highest miR-203 overexpression had significantly shorter survival time (P = 0.048 and P = 0.024, respectively). Multivariate analysis revealed that miR-203 expression was an independent predictor of poor prognosis in cases with no residual tumor (relative risk 2.298, P = 0.027).miR-203 expression is a new prognostic marker in pancreatic adenocarcinoma patients.